Skip to content

CHINA PHARMA HOLDINGS, INC.: 10-Q filed 2021-08-13

What CHINA PHARMA HOLDINGS, INC. reported in its quarterly report filed 2021-08-13 (fiscal Q2 2021): 45 published measures, 126 facts as tagged in accession 0001213900-21-042474.

This filing

Form
10-Q (quarterly report)
Filed
2021-08-13
Fiscal period
fiscal Q2 2021
Accession
0001213900-21-042474 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CHINA PHARMA HOLDINGS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-06-3019,944,241USD
At 2020-12-3121,117,991USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2021-06-3013,419,668USD
At 2020-12-3113,113,460USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-06-306,524,573USD
At 2021-03-317,165,879USD
At 2020-12-318,004,531USD
At 2020-06-308,398,521USD
At 2020-03-318,379,672USD
At 2019-12-319,237,601USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2021-06-301,754,868USD
At 2020-12-31957,653USD
At 2020-06-301,813,544USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-04-01 to 2021-06-30-824,761USD91
2021-01-01 to 2021-06-30-1,592,088USD181
2020-04-01 to 2020-06-3013,053USD91
2020-01-01 to 2020-06-30-647,844USD182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-01-01 to 2021-06-30399,120USD181
2020-01-01 to 2020-06-30-152,740USD182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2021-01-01 to 2021-06-3015,022USD181
2020-01-01 to 2020-06-30840,449USD182

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2021-04-01 to 2021-06-302,415,559USD91
2021-01-01 to 2021-06-304,773,930USD181
2020-04-01 to 2020-06-303,770,723USD91
2020-01-01 to 2020-06-305,534,678USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-01-01 to 2021-06-30402,886USD181
2020-01-01 to 2020-06-301,868,160USD182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2021-01-01 to 2021-06-30-15,022USD181
2020-01-01 to 2020-06-30-840,449USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-06-30-30,431,267USD
At 2020-12-31-28,839,179USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2021-06-3014,346,122USD
At 2020-12-3115,564,200USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-04-01 to 2021-06-30-752,948USD91
2021-01-01 to 2021-06-30-1,449,416USD181
2020-04-01 to 2020-06-3074,985USD91
2020-01-01 to 2020-06-30-524,295USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-06-305,263,370USD
At 2020-12-315,321,958USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2021-04-01 to 2021-06-3072,392USD91
2021-01-01 to 2021-06-30143,657USD181
2020-04-01 to 2020-06-3063,144USD91
2020-01-01 to 2020-06-30125,147USD182

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2021-06-3012,194,774USD
At 2020-12-3111,403,676USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2021-06-30164,942USD
At 2020-12-31182,146USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2021-04-01 to 2021-06-30823,948USD91
2021-01-01 to 2021-06-301,793,146USD181
2020-04-01 to 2020-06-301,074,813USD91
2020-01-01 to 2020-06-301,868,532USD182

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2021-06-302,978,060USD
At 2020-12-313,705,119USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2021-04-01 to 2021-06-3071,000USD91
2021-01-01 to 2021-06-30343,730USD181
2020-04-01 to 2020-06-301,149,798USD91
2020-01-01 to 2020-06-301,344,237USD182

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2021-04-01 to 2021-06-302,344,559USD91
2021-01-01 to 2021-06-304,430,200USD181
2020-04-01 to 2020-06-302,620,925USD91
2020-01-01 to 2020-06-304,190,441USD182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2021-04-01 to 2021-06-3053,456USD91
2021-01-01 to 2021-06-30243,542USD181
2020-04-01 to 2020-06-3030,044USD91
2020-01-01 to 2020-06-3078,863USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2021-06-3045,579,557shares
At 2020-12-3145,579,557shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2021-06-301,754,868USD
At 2020-12-31957,653USD
At 2020-06-302,036,540USD
At 2019-12-311,184,887USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2021-06-3024,452,684USD
At 2020-12-3124,452,684USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2021-06-3012,457,576USD
At 2020-12-3112,345,446USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2021-06-30169,807USD
At 2020-12-3149,687USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2021-06-30169,893USD
At 2020-12-3152,070USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2021-06-305,015,402USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2021-06-3040,475,351USD
At 2020-12-3140,063,527USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2021-06-3026,129,229USD
At 2020-12-3124,499,327USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2021-06-30164,942USD
At 2020-12-31182,146USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2021-06-30332,393USD
At 2020-12-31177,359USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2021-06-30525,579USD
At 2020-12-31719,786USD

Net deferred tax liabilities

Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.

PeriodValueUnitDays
At 2021-06-30813,636USD
At 2020-12-31805,556USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2021-04-01 to 2021-06-30-824,761USD91
2021-01-01 to 2021-06-30-1,592,088USD181
2020-04-01 to 2020-06-3013,053USD91
2020-01-01 to 2020-06-30-647,844USD182

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2021-04-01 to 2021-06-30-824,761USD91
2021-01-01 to 2021-03-31-767,327USD90
2020-04-01 to 2020-06-3013,053USD91
2020-01-01 to 2020-03-31-660,897USD91

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2021-04-01 to 2021-06-30-641,306USD91
2021-01-01 to 2021-06-30-1,479,958USD181
2020-04-01 to 2020-06-3018,849USD91
2020-01-01 to 2020-06-30-839,080USD182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2021-04-01 to 2021-06-30329,758USD91
2021-01-01 to 2021-06-30738,756USD181
2020-04-01 to 2020-06-30322,445USD91
2020-01-01 to 2020-06-30711,004USD182

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2021-04-01 to 2021-06-30690,943USD91
2021-01-01 to 2021-06-301,381,650USD181
2020-04-01 to 2020-06-30640,473USD91
2020-01-01 to 2020-06-301,287,586USD182

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2021-01-01 to 2021-06-301,400,647USD181
2020-01-01 to 2020-06-301,305,070USD182

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2021-04-01 to 2021-06-309,517USD91
2021-01-01 to 2021-06-3018,997USD181
2020-04-01 to 2020-06-308,676USD91
2020-01-01 to 2020-06-3017,484USD182

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2021-04-01 to 2021-06-30-71,813USD91
2021-01-01 to 2021-06-30-142,672USD181
2020-04-01 to 2020-06-30-61,932USD91
2020-01-01 to 2020-06-30-123,549USD182

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2021-01-01 to 2021-06-30121,090USD181
2020-01-01 to 2020-06-30118,374USD182

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-06-30-890,435USD181
2020-01-01 to 2020-06-3014,136USD182

Inspect the source

Entity
CHINA PHARMA HOLDINGS, INC. / CIK 0001106644
Captured
2026-09-20T05:23:28.377Z
SEC response SHA-256
ad45dffd15d0f5a098ab8b6912816a8b1b845b1d791781ea412833d3178873c0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001106644.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))